Masaud Shah

1.7k total citations · 1 hit paper
57 papers, 1.2k citations indexed

About

Masaud Shah is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Masaud Shah has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Immunology and 13 papers in Epidemiology. Recurrent topics in Masaud Shah's work include Immune Response and Inflammation (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Masaud Shah is often cited by papers focused on Immune Response and Inflammation (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Masaud Shah collaborates with scholars based in South Korea, Pakistan and United States. Masaud Shah's co-authors include Sangdun Choi, Hyun Goo Woo, Muhammad Ayaz Anwar, Jason Kim, Maria Batool, Prasannavenkatesh Durai, Mahesh Chandra Patra, Abdul Wadood, Suresh Panneerselvam and Dhanusha Yesudhas and has published in prestigious journals such as PLoS ONE, Biomaterials and Hepatology.

In The Last Decade

Masaud Shah

52 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies

2022 164 citations Masaud Shah, Hyun Goo Woo Frontiers in Immunology profile →

Peers

Countries citing papers authored by Masaud Shah

Since Specialization

Citations

This map shows the geographic impact of Masaud Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaud Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaud Shah more than expected).

Fields of papers citing papers by Masaud Shah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaud Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaud Shah. The network helps show where Masaud Shah may publish in the future.

Co-authorship network of co-authors of Masaud Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Masaud Shah. A scholar is included among the top collaborators of Masaud Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaud Shah. Masaud Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural insights into antibody-based immunotherapy for hepatocellular carcinoma 2025 ·Genomics & Informatics ·Masaud Shah, Muhammad Hussain, Hyun Goo Woo	2
2	Peptide Therapeutics: AI-Driven Design and Structural Bioengineering 2025 ·Masaud Shah, Hyun Woo Goo	0
3	Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations 2024 ·International Journal of Biological Macromolecules ·Abdul Nasır, Abdus Samad, Amar Ajmal, Ping Li, Muhammad Torequl Islam, (unknown), Masaud Shah, Qian Bai	3
4	Improving Access to Anti-HDV Testing: Development and Validation of an Affordable In-House ELISA Assay 2024 ·ACS Omega ·Iram Amin, Shazia Rafique, Amjad Ali, Nadeem Ahmed, Muhammad Shahid, Samia Afzal, Saad Tahir, Muhammad Waqas, Sadia Bibi, Abdallah M. Elgorban, Muhammad Idrees, Masaud Shah, Asad Syed	0
5	Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as MASLD progression markers 2024 ·Hepatology ·Do Yoon Kim, Masaud Shah, (unknown), (unknown), Yang Hyun Baek, Jin‐Sook Jeong, (unknown), Yong Sun Lee, (unknown), (unknown), Young Hoon Roh, Sungwook Lee, (unknown), Jong Hoon Park, Kyung Hyun Yoo, Rho Hyun Seong, Yeon-Su Lee, Hyun Goo Woo	3
6	RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression 2024 ·Anticancer Research ·(unknown), (unknown), Masaud Shah, Sukjoon Yoon, Hyun Goo Woo	1
7	Long Non-coding RNA TPRG1-AS1 Interacts With CLTC in Liver Cancer Cells 2024 ·Anticancer Research ·(unknown), Masaud Shah, (unknown), Hyun Goo Woo	0
8	Leveraging deep transfer learning and explainable AI for accurate COVID-19 diagnosis: Insights from a multi-national chest CT scan study 2024 ·Computers in Biology and Medicine ·Nhat Truong Pham, (unknown), Masaud Shah, (unknown), Hyun Goo Woo, Balachandran Manavalan	2
9	Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping 2023 ·Frontiers in Molecular Biosciences ·Masaud Shah, Hyun Goo Woo	0
10	Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction 2023 ·Frontiers in Immunology ·Masaud Shah, (unknown), Hyun Goo Woo	2
11	The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs 2022 ·Molecular Therapy ·Masaud Shah, Hyun Goo Woo	5
12	Pneumococcal pep27-mutant inhibits Wnt5a expression via the regulation of T helper cells to attenuate colitis 2022 ·International Immunopharmacology ·(unknown), (unknown), (unknown), Prachetash Ghosh, Masaud Shah, Wonsik Lee, Dong‐Kwon Rhee	3
13	TPRG1‐AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR‐4691‐5p and miR‐3659 2021 ·Liver International ·Ji Hye Choi, So Mee Kwon, (unknown), Sarah Yoon, Masaud Shah, (unknown), (unknown), Young Nyun Park, (unknown), Hyun Goo Woo	12
14	USO1 isoforms differentially promote liver cancer progression by dysregulating the ER–Golgi network 2021 ·Carcinogenesis ·Sarah Yoon, Ji Hye Choi, Masaud Shah, So Mee Kwon, (unknown), Young Nyun Park, Hee-Jung Wang, Hyun Goo Woo	3
15	Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions 2021 ·Molecules and Cells ·Masaud Shah, Hyun Goo Woo	18
16	A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models 2020 ·EBioMedicine ·Asma Achek, Hyuk‐Kwon Kwon, Mahesh Chandra Patra, Masaud Shah, (unknown), Wang‐Hee Lee, Wook‐Young Baek, (unknown), Gi‐Young Kim, (unknown), Chang‐Hee Suh, Wook Kim, Dae‐Hyun Hahm, Sangdun Choi	16
17	EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression 2019 ·Experimental & Molecular Medicine ·Sarah Yoon, Ji Hye Choi, Sung Joo Kim, Eun‐Ju Lee, Masaud Shah, Sangdun Choi, Hyun Goo Woo	16
18	A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach 2016 ·Scientific Reports ·Masaud Shah, Muhammad Ayaz Anwar, Dhanusha Yesudhas, Jayalakshmi Krishnan, Sangdun Choi	26
19	Interaction and Inhibition of Dengue Envelope Glycoprotein with Mammalian Receptor DC-Sign, an In-Silico Approach 2013 ·PLoS ONE ·Masaud Shah, Abdul Wadood, Ziaur S. M. Rahman, Tayyab Husnaın	22
20	Molecular docking study of P4-Benzoxaborole-substituted ligands as inhibitors of HCV NS3/4A protease 2013 ·Bioinformation ·Abdul Wadood, Muhammad Riaz, Syed Babar Jamal, Masaud Shah, Muhammad Arif Lodhi	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact